FDA-Approved Tedizolid Phosphate Prevents Cisplatin-Induced Hearing Loss Without Decreasing Its Anti-tumor Effect. - Yao Z; Xiao Y; Li W; Kong S; Tu H; Guo S; Liu Z; Ma L; Qiao R; Wang S; Chang M; Zhao X; et al. (Journal of the Association for Research in Otolaryngology : JARO, 2024)